Inhaled nitric oxide and acute kidney injury risk: a meta-analysis of randomized controlled trials.

PURPOSE

There are conflicting results as to the effect of inhaled nitric oxide (iNO) therapy on the risk of acute kidney injury (AKI). The aim of this study was to perform a meta-analysis to assess the updated data.

METHODS

We systematically searched Web of Science, the Cochrane Library, Wanfang, and PubMed for relevant randomized control trials between database inception and 9/07/2020. Relative risks (RRs) with 95% confidence intervals (CIs) predicting the risk of AKI were extracted to obtain summary estimates using fixed-effects models. The Trim and Fill method was used to evaluate the sensitivity of the results and adjust for publication bias in meta-analysis.

RESULTS

15 randomized controlled studies from 14 articles involving 1853 patients were included in the study. Analyzing the eligible studies we found: (1) iNO therapy significantly increased the risk of AKI in acute respiratory distress syndrome patients (RR 1.55, 95% CI 1.15-2.10,  = 0.004; for heterogeneity 0%; = 0.649). (2) The use of iNO was associated with reduced AKI risk in patients undergoing cardiac surgery (RR 0.80, 95% CI 0.64-0.99,  = 0.037; for heterogeneity 0%; = 0.528). (3) For organ transplantation recipients, there was no effect of iNO administration on the risk of AKI (RR 0.50, 95% CI 0.16-1.56,  = 0.233; for heterogeneity 0%; = 0.842). The Trim and Fill analysis showed that the overall effect of this meta-analysis was stable.

CONCLUSIONS

The effect of iNO on AKI risk might be disease-specific. Future RCTs with larger patient populations should aim to validate our findings.